Willis Towers Watson
7 Ways COVID-19 Will Transform Health Care
The pandemic could promote disruptive innovation to lower costs, but it will take pressure from the business community to make it happen.
Health Benefit Costs Seen Rising 8.1% in 2021
The coronavirus had "a major impact" on slowing medical cost growth this year but the trend "is expected to be short-lived," a survey finds.
Aon to Buy Willis Towers Watson
The $30 billion deal creates the world’s largest insurance brokerage.
More CEOs Must Retain Equity Awards Post-Vesting
If current trends hold, eventually stock-retention requirements for CEOs may be almost as universal as equity ownership requirements.
Acquirers Again Underperformed the Broader Market in 2019
Dealmakers' share-price performance trailed the MSCI World Index by five points, and deal volume sank as tensions left companies in wait-and-see mode.
Pension Plans’ Struggles Continue Despite Big Investment Gains
While 2019 was a banner year for returns, low interest rates prevented plan sponsors from meaningfully improving their funded states.
Share Prices Plummet Following Divestitures in 2019
Almost two-thirds of companies are seeing their stock prices underperform industry benchmarks, with the average underperformance at 7%.
Pay Increases to Remain Flat in 2020: Study
Employers are setting aside more for discretionary bonuses to top performers.
M&A Market Guts Shareholder Value in Second Quarter
Shares of deal-making companies worldwide underperform MSCI stock indices for a record seventh consecutive quarter.
Aon Not Pursuing Willis Towers Watson Deal
Due to media speculation, Aon was forced to disclose it was in the preliminary stages of an all-share deal.
The Link Between Divestitures and Share-Price Malaise
An extensive study counterintuitively reveals that a majority of divestitures are accompanied by lagging stock performance for the divesting firm.